Literature DB >> 25453189

The melanocortin-4 receptor is expressed in enteroendocrine L cells and regulates the release of peptide YY and glucagon-like peptide 1 in vivo.

Brandon L Panaro1, Iain R Tough2, Maja S Engelstoft3, Robert T Matthews1, Gregory J Digby1, Cathrine L Møller4, Berit Svendsen5, Fiona Gribble6, Frank Reimann6, Jens J Holst7, Birgitte Holst8, Thue W Schwartz8, Helen M Cox2, Roger D Cone9.   

Abstract

The melanocortin-4 receptor (MC4R) is expressed in the brainstem and vagal afferent nerves and regulates a number of aspects of gastrointestinal function. Here we show that the receptor is also diffusely expressed in cells of the gastrointestinal system, from stomach to descending colon. Furthermore, MC4R is the second most highly enriched GPCR in peptide YY (PYY) and glucagon-like peptide 1 (GLP-1) expressing enteroendocrine L cells. When vectorial ion transport is measured across mouse or human intestinal mucosa, administration of α-MSH induces a MC4R-specific PYY-dependent antisecretory response consistent with a role for the MC4R in paracrine inhibition of electrolyte secretion. Finally, MC4R-dependent acute PYY and GLP-1 release from L cells can be stimulated in vivo by intraperitoneal (i.p.) administration of melanocortin peptides to mice. This suggests physiological significance for MC4R in L cells and indicates a previously unrecognized peripheral role for the MC4R, complementing vagal and central receptor functions.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25453189      PMCID: PMC4255280          DOI: 10.1016/j.cmet.2014.10.004

Source DB:  PubMed          Journal:  Cell Metab        ISSN: 1550-4131            Impact factor:   27.287


  41 in total

1.  Targeted disruption of the melanocortin-4 receptor results in obesity in mice.

Authors:  D Huszar; C A Lynch; V Fairchild-Huntress; J H Dunmore; Q Fang; L R Berkemeier; W Gu; R A Kesterson; B A Boston; R D Cone; F J Smith; L A Campfield; P Burn; F Lee
Journal:  Cell       Date:  1997-01-10       Impact factor: 41.582

2.  Gut hormone PYY(3-36) physiologically inhibits food intake.

Authors:  Rachel L Batterham; Michael A Cowley; Caroline J Small; Herbert Herzog; Mark A Cohen; Catherine L Dakin; Alison M Wren; Audrey E Brynes; Malcolm J Low; Mohammad A Ghatei; Roger D Cone; Stephen R Bloom
Journal:  Nature       Date:  2002-08-08       Impact factor: 49.962

3.  Brainstem application of melanocortin receptor ligands produces long-lasting effects on feeding and body weight.

Authors:  H J Grill; A B Ginsberg; R J Seeley; J M Kaplan
Journal:  J Neurosci       Date:  1998-12-01       Impact factor: 6.167

4.  A major lineage of enteroendocrine cells coexpress CCK, secretin, GIP, GLP-1, PYY, and neurotensin but not somatostatin.

Authors:  Kristoffer L Egerod; Maja S Engelstoft; Kaare V Grunddal; Mark K Nøhr; Anna Secher; Ichiro Sakata; Jens Pedersen; Johanne A Windeløv; Ernst-Martin Füchtbauer; Jørgen Olsen; Frank Sundler; Jan P Christensen; Nils Wierup; Jesper V Olsen; Jens J Holst; Jeffrey M Zigman; Steen S Poulsen; Thue W Schwartz
Journal:  Endocrinology       Date:  2012-10-12       Impact factor: 4.736

5.  Peptide YY is critical for acylethanolamine receptor Gpr119-induced activation of gastrointestinal mucosal responses.

Authors:  Helen M Cox; Iain R Tough; Anne-Marie Woolston; Lei Zhang; Amy D Nguyen; Amanda Sainsbury; Herbert Herzog
Journal:  Cell Metab       Date:  2010-06-09       Impact factor: 27.287

6.  Leptin receptor signaling in POMC neurons is required for normal body weight homeostasis.

Authors:  Nina Balthasar; Roberto Coppari; Julie McMinn; Shun M Liu; Charlotte E Lee; Vinsee Tang; Christopher D Kenny; Robert A McGovern; Streamson C Chua; Joel K Elmquist; Bradford B Lowell
Journal:  Neuron       Date:  2004-06-24       Impact factor: 17.173

7.  Differential influence of a selective melanocortin MC4 receptor antagonist (HS014) on melanocortin-induced behavioral effects in rats.

Authors:  A V Vergoni; A Bertolini; F Mutulis; J E Wikberg; H B Schiöth
Journal:  Eur J Pharmacol       Date:  1998-12-04       Impact factor: 4.432

8.  Localization of the melanocortin-4 receptor (MC4-R) in neuroendocrine and autonomic control circuits in the brain.

Authors:  K G Mountjoy; M T Mortrud; M J Low; R B Simerly; R D Cone
Journal:  Mol Endocrinol       Date:  1994-10

9.  Glucagon-like peptide-1 (7-36)amide and glucose-dependent insulinotropic polypeptide secretion in response to nutrient ingestion in man: acute post-prandial and 24-h secretion patterns.

Authors:  R M Elliott; L M Morgan; J A Tredger; S Deacon; J Wright; V Marks
Journal:  J Endocrinol       Date:  1993-07       Impact factor: 4.286

10.  Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41.

Authors:  Buck S Samuel; Abdullah Shaito; Toshiyuki Motoike; Federico E Rey; Fredrik Backhed; Jill K Manchester; Robert E Hammer; S Clay Williams; Jan Crowley; Masashi Yanagisawa; Jeffrey I Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-17       Impact factor: 11.205

View more
  57 in total

1.  The stimulatory G protein Gsα is required in melanocortin 4 receptor-expressing cells for normal energy balance, thermogenesis, and glucose metabolism.

Authors:  Brandon Podyma; Hui Sun; Eric A Wilson; Bradley Carlson; Ethan Pritikin; Oksana Gavrilova; Lee S Weinstein; Min Chen
Journal:  J Biol Chem       Date:  2018-05-24       Impact factor: 5.157

2.  Late onset obesity in mice with targeted deletion of potassium inward rectifier Kir7.1 from cells expressing the melanocortin-4 receptor.

Authors:  Erica J P Anderson; Masoud Ghamari-Langroudi; Isin Cakir; Michael J Litt; Valerie Chen; Roman E Reggiardo; Glenn L Millhauser; Roger D Cone
Journal:  J Neuroendocrinol       Date:  2019-01-20       Impact factor: 3.627

Review 3.  Roux-en-Y gastric bypass: effects on feeding behavior and underlying mechanisms.

Authors:  Sean Manning; Andrea Pucci; Rachel L Batterham
Journal:  J Clin Invest       Date:  2015-03-02       Impact factor: 14.808

4.  Weight Loss After RYGB Is Independent of and Complementary to Serotonin 2C Receptor Signaling in Male Mice.

Authors:  Jill S Carmody; Nadia N Ahmad; Sriram Machineni; Scott Lajoie; Lee M Kaplan
Journal:  Endocrinology       Date:  2015-06-11       Impact factor: 4.736

Review 5.  Role of eating disorders-related polymorphisms in obesity pathophysiology.

Authors:  Carolina Ferreira Nicoletti; Heitor Bernardes Pereira Delfino; Flávia Campos Ferreira; Marcela Augusta de Souza Pinhel; Carla Barbosa Nonino
Journal:  Rev Endocr Metab Disord       Date:  2019-03       Impact factor: 6.514

6.  Melanocortin Receptor 4 Signaling Regulates Vertebrate Limb Regeneration.

Authors:  Mengshi Zhang; Youwei Chen; Hanqian Xu; Li Yang; Feng Yuan; Lei Li; Ying Xu; Ying Chen; Chao Zhang; Gufa Lin
Journal:  Dev Cell       Date:  2018-08-20       Impact factor: 12.270

Review 7.  Ghrelin, CCK, GLP-1, and PYY(3-36): Secretory Controls and Physiological Roles in Eating and Glycemia in Health, Obesity, and After RYGB.

Authors:  Robert E Steinert; Christine Feinle-Bisset; Lori Asarian; Michael Horowitz; Christoph Beglinger; Nori Geary
Journal:  Physiol Rev       Date:  2017-01       Impact factor: 37.312

8.  Comparative Intracerebroventricular and Intrathecal Administration of a Nanomolar Macrocyclic Melanocortin Receptor Agonist MDE6-5-2c (c[Pro-His-DPhe-Arg-Trp-Dap-Ala-DPro]) Decreases Food Intake in Mice.

Authors:  Danielle N Adank; Mary M Lunzer; Mark D Ericson; Zoe M Koeperich; Stacey L Wilber; Katlyn A Fleming; Carrie Haskell-Luevano
Journal:  ACS Chem Neurosci       Date:  2020-09-10       Impact factor: 4.418

Review 9.  The melanocortin pathway and control of appetite-progress and therapeutic implications.

Authors:  Giulia Baldini; Kevin D Phelan
Journal:  J Endocrinol       Date:  2019-04-01       Impact factor: 4.286

10.  G(q/11)α and G(s)α mediate distinct physiological responses to central melanocortins.

Authors:  Yong-Qi Li; Yogendra Shrestha; Mritunjay Pandey; Min Chen; Ahmed Kablan; Oksana Gavrilova; Stefan Offermanns; Lee S Weinstein
Journal:  J Clin Invest       Date:  2015-11-23       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.